John Gallagher Sells 430 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 430 shares of the company’s stock in a transaction dated Monday, March 30th. The shares were sold at an average price of $25.47, for a total value of $10,952.10. Following the completion of the sale, the chief operating officer owned 31,957 shares of the company’s stock, valued at $813,944.79. This represents a 1.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Trupanion Trading Up 0.8%

Shares of TRUP stock traded up $0.20 on Thursday, reaching $25.64. The company had a trading volume of 46,865 shares, compared to its average volume of 462,487. The stock has a market cap of $1.11 billion, a PE ratio of 56.98 and a beta of 1.66. The company has a 50-day moving average of $28.46 and a 200-day moving average of $35.39. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. Trupanion, Inc. has a 12 month low of $24.32 and a 12 month high of $57.88.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The firm had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. During the same quarter last year, the business posted $0.04 earnings per share. The company’s revenue for the quarter was up 11.7% on a year-over-year basis. On average, equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Cantor Fitzgerald lowered their target price on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Weiss Ratings downgraded shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Finally, Stifel Nicolaus lowered their price objective on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $44.50.

Institutional Trading of Trupanion

A number of institutional investors have recently modified their holdings of the company. Campbell & CO Investment Adviser LLC bought a new position in shares of Trupanion during the third quarter worth about $3,772,000. GSA Capital Partners LLP lifted its stake in Trupanion by 827.3% in the 3rd quarter. GSA Capital Partners LLP now owns 44,584 shares of the financial services provider’s stock valued at $1,930,000 after acquiring an additional 39,776 shares in the last quarter. Tudor Investment Corp ET AL lifted its stake in Trupanion by 183.7% in the 3rd quarter. Tudor Investment Corp ET AL now owns 237,125 shares of the financial services provider’s stock valued at $10,263,000 after acquiring an additional 153,530 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in Trupanion during the 3rd quarter worth approximately $1,897,000. Finally, JPMorgan Chase & Co. boosted its position in Trupanion by 66.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider’s stock worth $8,955,000 after acquiring an additional 64,704 shares during the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.